BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8753011)

  • 1. [Intravesical oxybutynin hydrochloride in the treatment of urge incontinence in the elderly].
    Mizunaga M; Miyata M; Kaneko S; Taniguchi N; Yachiku S; Chiba K; Osanai H; Fujisawa M
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):923-7. PubMed ID: 8753011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience.
    Saito M; Watanabe T; Tabuchi F; Otsubo K; Satoh K; Miyagawa I
    Int J Urol; 2004 Aug; 11(8):592-6. PubMed ID: 15285747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
    Lehtoranta K; Tainio H; Lukkari-Lax E; Hakonen T; Tammela TL
    Scand J Urol Nephrol; 2002 Feb; 36(1):18-24. PubMed ID: 12002352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravesical drug therapy in women with severe urge incontinence. Clinical experiences from a department of gynecology].
    Johansen JK; Lose G
    Ugeskr Laeger; 1999 Nov; 161(44):6052-5. PubMed ID: 10778341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
    Lose G; Nørgaard JP
    BJU Int; 2001 Jun; 87(9):767-73. PubMed ID: 11412211
    [No Abstract]   [Full Text] [Related]  

  • 6. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
    Enzelsberger H; Kurz C; Helmer H; Mittermayer F
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients.
    Connor JP; Betrus G; Fleming P; Perlmutter AD; Reitelman C
    J Urol; 1994 Apr; 151(4):1045-7. PubMed ID: 8126787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
    O'Flynn KJ; Thomas DG
    Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients.
    Haferkamp A; Staehler G; Gerner HJ; Dörsam J
    Spinal Cord; 2000 Apr; 38(4):250-4. PubMed ID: 10822396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravesical treatment of overactive bladder syndrome].
    Haferkamp A; Hohenfellner M
    Urologe A; 2006 Oct; 45(10):1283-8. PubMed ID: 16972089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical oxybutynin chloride: experience with 42 patients.
    Weese DL; Roskamp DA; Leach GE; Zimmern PE
    Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical oxybutynin: practicalities of clinical use.
    Guerrero K; Emery S; Owen L; Rowlands M
    J Obstet Gynaecol; 2006 Feb; 26(2):141-3. PubMed ID: 16483973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical therapy for the treatment of neurogenic bladder in children.
    Holland AJ; King PA; Chauvel PJ; O'Neill MK; McKnight DL; Barker AP
    Aust N Z J Surg; 1997 Oct; 67(10):731-3. PubMed ID: 9322726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects.
    Bemelmans BL; Kiemeney LA; Debruyne FM
    Eur Urol; 2000 Jun; 37(6):709-13. PubMed ID: 10828672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group.
    Anderson RU; Mobley D; Blank B; Saltzstein D; Susset J; Brown JS
    J Urol; 1999 Jun; 161(6):1809-12. PubMed ID: 10332441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder.
    Kaplinsky R; Greenfield S; Wan J; Fera M
    J Urol; 1996 Aug; 156(2 Pt 2):753-6. PubMed ID: 8683776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical oxybutynin for spinal cord injury patients.
    Szollar SM; Lee SM
    Spinal Cord; 1996 May; 34(5):284-7. PubMed ID: 8963976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.